57 related articles for article (PubMed ID: 3007819)
1. [Antinephritic effect of SA-446, an angiotensin I converting enzyme inhibitor, on crescentic-type anti-GBM nephritis in rats].
Suzuki Y; Ito M; Yamada H; Saitho N; Tsukushi Y
Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1485-93. PubMed ID: 3007819
[No Abstract] [Full Text] [Related]
2. Studies on mechanisms of antinephritic action of SA-446 an angiotensin I converting enzyme inhibitor (1). A comparison with actions of spironolactone, kallidinogenase and saralasin.
Suzuki Y; Ito M; Saito N
Jpn J Pharmacol; 1986 Dec; 42(4):465-75. PubMed ID: 3027437
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 in spontaneously hypertensive rats.
Unger T; Rockhold RW; Bönner G; Rascher W; Schaz K; Speck G; Schömig A; Ganten D
Clin Exp Hypertens (1978); 1981; 3(1):121-40. PubMed ID: 6258887
[No Abstract] [Full Text] [Related]
4. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
Takata Y; Di Nicolantonio R; Hutchinson JS
Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635
[No Abstract] [Full Text] [Related]
6. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
Komori T; Takada T; Funae Y; Yamamoto K
Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
[No Abstract] [Full Text] [Related]
7. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril.
Yamauchi H; Nishimura K; Nakata K; Suda H; Iso T; Shimizu M; Hiramatsu Y
Arzneimittelforschung; 1987 Feb; 37(2):157-64. PubMed ID: 3034298
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin converting enzyme inhibitor (SA-446) on regional hemodynamics in renal and spontaneously hypertensive rats.
Abe Y; Sakamoto W; Fukui K; Iwao H; Takada T; Yamamoto K
Arch Int Pharmacodyn Ther; 1988; 292():237-47. PubMed ID: 3395170
[TBL] [Abstract][Full Text] [Related]
9. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
[No Abstract] [Full Text] [Related]
10. A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421.
Takata Y; Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
Clin Exp Pharmacol Physiol; 1983; 10(2):131-45. PubMed ID: 6307563
[No Abstract] [Full Text] [Related]
11. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological studies on the diuretic action of azosemide [5-(4'-chloro-5'-sulfamoyl-2'-thenylamino)-phenyltetrazole], a new diuretic (3). Effect of azosemide following pretreatment with SA-446, an angiotensin I converting enzyme inhibitor, or propranolol, a beta-adrenergic blocker, in HgCl2-induced acute renal failure in rats].
Suzuki Y; Ito M; Komura T
Nihon Yakurigaku Zasshi; 1982 Nov; 80(5):395-404. PubMed ID: 6187650
[No Abstract] [Full Text] [Related]
13. Effects of three different kininase II inhibitors on blood pressure and renal vasoactive substances in essential hypertensives.
Abe K; Tajima J; Omata K; Tanno M; Tsunoda K; Kudo K; Onoda Y; Kohzuki M; Sasaki S; Takeuchi K
Adv Exp Med Biol; 1986; 198 Pt B():269-77. PubMed ID: 3028076
[No Abstract] [Full Text] [Related]
14. [Potentiative effects of angiotensin converting enzyme inhibitors on carrageenan-induced edema in rats].
Suda H; Yamauchi H; Iso T
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):517-23. PubMed ID: 6298082
[TBL] [Abstract][Full Text] [Related]
15. [Antinephritic effect of tiaramide on experimental nephritis in rats. (1). Effects on nephrotic-type and crescentic-type anti-GBM nephritis].
Suzuki Y; Ito M; Saito N; Nagamatsu T
Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):251-61. PubMed ID: 6748338
[No Abstract] [Full Text] [Related]
16. Mechanisms of converting enzyme inhibition: studies in experimental animals.
Dinicolantonio R; Mendelsohn FA; Takata Y; Hutchinson JS; Doyle AE
Neth J Med; 1984; 27(4):153-60. PubMed ID: 6330589
[No Abstract] [Full Text] [Related]
17. Effects of angiotensin-converting enzyme inhibitors on the vascular response to norepinephrine.
Saruta T; Suzuki H; Okuno T; Kondo K
Am J Cardiol; 1982 Apr; 49(6):1535-6. PubMed ID: 6176110
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of angiotensin I converting enzyme: (4R)-3-[(2S)-3-mercapto-2-methylpropanoyl]-4-thiazolidinecarboxylic acid (YS-980).
Funae Y; Komori T; Sasaki D; Yamamoto K
Biochem Pharmacol; 1980 Jun; 29(11):1543-7. PubMed ID: 6249321
[No Abstract] [Full Text] [Related]
19. [Antinephritic effect of trimetazidine on nephrotic-type and crescentic-type anti-GBM nephritis in rats].
Suzuki Y; Ito M; Saito N
Nihon Jinzo Gakkai Shi; 1985 Feb; 27(2):209-19. PubMed ID: 4021185
[No Abstract] [Full Text] [Related]
20. Effects of angiotensin I-converting enzyme inhibitor (SA-446) on renal function in dogs.
Takada T; Yamamoto K; Fujioka S; Tamaki T; Fukui K; Abe Y
Jpn J Pharmacol; 1985 Jun; 38(2):227-30. PubMed ID: 2993720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]